There was a high degree of consistency in the documentation of a clinically meaningful correction during the study, as measured independently by the investigators and subjects using the GAIS instrument.
Study period lasted for eight weeks, and subjects used the dawn simulators for two weeks at a time, each subject acting as his own control (ABAB-design).
The average true positive rate, false discovery rate, and Dice's coefficient for this subject using the C-CNN were found to be 0.993, 0.007, and 0.993, respectively.
Supplementary Tables S1 S4 provide the parameter estimates and their FSDs estimated for each subject using the Jacobian method.
To investigate whether there are differences in brain connectivity in late-life depression (LLD) and nondepressed subjects using the left and right heads of caudate nuclei (hCN) as the seed regions.
To analyze and compare corneal biomechanical properties in healthy black and white subjects using the Ocular Response Analyzer (ORA) and to evaluate their relationship with other ocular parameters.
For Studies 1 and 2, the clinical characteristics were compared between CAD patients and control subjects using the chi-square test for categorical variables and 2-tailed Student t-tests t-testsoron test (for non-normally distributed triglycerides levels) for continuous variables.
To test the intrasession reproducibility of RNFL thickness measurements in patients with PD and healthy subjects using the Cirrus (Carl Zeiss Meditec Inc., Dublin, CA) and Spectralis (Heidelberg Engineering, Inc., Heidelberg, Germany) OCT devices.
In this study, the variability of tracer uptake in the rodent brain was assessed within and between subjects using the established radiopharmaceuticals 18F-FDG and 18F-fallypride.
To compute odds ratios (ORs), serum measurements were categorised into quintiles separately for pre- and postmenopausal subjects, using the frequency distribution of the cases and the controls combined.
